NVAX · Novavax Inc · Proposed Sales
$10.46
-0.14 (-1.32%)
At close · Oct 2
Return incl. dividend (before tax)
Market Cap
$1.75B
Shares
164.95M
Volume · Oct 2
4.03M
Avg daily vol (3M)
4.45M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2025-05-19 | YOUNG JAMES F | Former Director | 10,000 | 2025-05-19 | Merrill Lynch |
| 2025-04-14 | YOUNG JAMES F | Former Director | 4,000 | 2025-04-14 | Merrill Lynch |
| 2024-12-26 | YOUNG JAMES F | Director | 10,000 | 2024-12-24 | Merrill Lynch |
| 2024-12-13 | Rachel K. King | Board Member | 4,150 | 2024-12-13 | UBS Financial Services Inc |
| 2024-09-18 | Dubovsky Filip | Officer | 7,335 | 2024-09-18 | Merrill Lynch |
| 2024-06-18 | YOUNG JAMES F | Director | 15,000 | 2024-06-18 | Merrill Lynch |
| 2024-06-17 | Dubovsky Filip | Officer | 13,904 | 2024-06-17 | Merrill Lynch |
| 2024-05-14 | Dubovsky Filip | Officer | 47,312 | 2024-05-14 | Merrill Lynch |
Showing 1–8 of 8 filings